Chemoinformaics analysis of SWIETENOLIDE-3-ACETATE
| Molecular Weight | 528.598 | nRot | 4 |
| Heavy Atom Molecular Weight | 492.31 | nRig | 29 |
| Exact Molecular Weight | 528.236 | nRing | 5 |
| Solubility: LogS | -4.254 | nHRing | 2 |
| Solubility: LogP | 3.041 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 5 |
| nHA | 9 | APOL | 79.6525 |
| nHD | 1 | BPOL | 46.5315 |
| QED | 0.353 |
| Synth | 5.953 |
| Natural Product Likeliness | 2.978 |
| NR-PPAR-gamma | 0.813 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.985 |
| Pgp-sub | 0.691 |
| HIA | 0.108 |
| CACO-2 | -5.184 |
| MDCK | 0.0000937 |
| BBB | 0.479 |
| PPB | 0.807364 |
| VDSS | 1.157 |
| FU | 0.195024 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.096 |
| CYP2c19-inh | 0.077 |
| CYP2c19-sub | 0.602 |
| CYP2c9-inh | 0.415 |
| CYP2c9-sub | 0.094 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.667 |
| CYP3a4-sub | 0.616 |
| CL | 11.308 |
| T12 | 0.053 |
| hERG | 0.002 |
| Ames | 0.03 |
| ROA | 0.992 |
| SkinSen | 0.023 |
| Carcinogencity | 0.166 |
| EI | 0.056 |
| Respiratory | 0.972 |
| NR-Aromatase | 0.022 |
| Antiviral | Yes |
| Prediction | 0.825386 |